Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00673322 · ClinicalTrials.gov registry record · Phase 1
Trial of Second Generation Designer T Cells in Colorectal Carcinoma
A Phase 1 study, sponsored by Roger Williams Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00673322 is a Phase 1 study that was terminated before completion, run by Roger Williams Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT00673322, a Phase 1 study, was terminated before completion, sponsored by Roger Williams Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recognize the tumor antigen (CEA). These modified cells are then given back into the participant so that they can attack and kill tumor cells.
Interventions
- BIOLOGICAL Gene Modified T Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00673322
The ClinicalTrials.gov registry entry for NCT00673322 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roger Williams Medical Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gene Modified T Cells is the first listed.
NCT00673322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00673322 about?
NCT00673322 is a clinical study titled "Trial of Second Generation Designer T Cells in Colorectal Carcinoma". The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recogn...
What is the current status of trial NCT00673322?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2008-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00673322?
The interventions under investigation include: Gene Modified T Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00673322?
This trial is sponsored by Roger Williams Medical Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.